PITPNA and prostate carcinoma: Furthermore, miR-129-5p inhibitor partially restored the suppressive effect of PITPNA-AS1 knockdown on the proliferation and activity of prostate cancer cells, and this was also indicated by Western blot assay of cellular markers.